Patents by Inventor Velasco CIMICA

Velasco CIMICA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human respiratory syncytial virus (HRSV) virus-like particles (VLPS) based vaccine
    Patent number: 11324816
    Abstract: Described herein are virus-like particles (VLPs) that display on their surfaces antigenic paramyxovirus (e.g., RSV and/or MPV) proteins. Also described are methods of making and using these VLPs.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: May 10, 2022
    Assignee: TechnoVax, Inc.
    Inventors: Jose M. Galarza, Velasco Cimica, Hélène Boigard
  • Virus-like particles comprising zika antigen
    Patent number: 11179460
    Abstract: The invention is related to chimeric Virus-Like Particles (VLPs) containing and displaying epitopes and antigen from Zika Virus (ZIKV); and to methods for creation and production of such chimeric VLPs to their applications, including but not limited to vaccines, diagnostics, clinical studies, assay development and antibody discovery.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: November 23, 2021
    Assignee: American Type Culture Collection (ATCC)
    Inventor: Velasco Cimica
  • VIRUS-LIKE PARTICLES COMPRISING ZIKA ANTIGEN
    Publication number: 20200171143
    Abstract: The invention is related to chimeric Virus-Like Particles (VLPs) containing and displaying epitopes and antigen from Zika Virus (ZIKV); and to methods for creation and production of such chimeric VLPs to their applications, including but not limited to vaccines, diagnostics, clinical studies, assay development and antibody discovery.
    Type: Application
    Filed: June 22, 2018
    Publication date: June 4, 2020
    Inventor: Velasco Cimica
  • HUMAN RESPIRATORY SYNCYTIAL VIRUS (HRSV) VIRUS-LIKE PARTICLES (VLPS) BASED VACCINE
    Publication number: 20190030156
    Abstract: Described herein are virus-like particles (VLPs) that display on their surfaces antigenic paramyxovirus (e.g., RSV and/or MPV) proteins. Also described are methods of making and using these VLPs.
    Type: Application
    Filed: August 29, 2016
    Publication date: January 31, 2019
    Applicant: TechnoVax, Inc.
    Inventors: Jose M. GALARZA, Velasco CIMICA, Hélène BOIGARD